Aggravation of pulmonary fibrosis after knocking down the aryl hydrocarbon receptor in the insulin‐like growth factor 1 receptor pathway-Reference-Cited by-同舟云学术

Aggravation of pulmonary fibrosis after knocking down the aryl hydrocarbon receptor in the insulin‐like growth factor 1 receptor pathway

Published:2022-02-28 Issue:13 Volume:179 Page:3430-3451
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British J Pharmacology

Author:

Wu Sheng‐Mao¹^ORCID,Tsai Jaw‐Ji²,Pan Hung‐Chuan³⁴⁵,Arbiser Jack L.⁶,Elia Leonardo⁷⁸^ORCID,Sheu Meei‐Ling¹⁴⁵^ORCID

Affiliation:

1. Institute of Biomedical Sciences National Chung Hsing University Taichung Taiwan

2. Division of Allergy, Immunology & Rheumatology, Department of Internal Medicine Asia University Hospital Taichung Taiwan

3. Department of Neurosurgery Taichung Veterans General Hospital Taichung Taiwan

4. Department of Medical Research Taichung Veterans General Hospital Taichung Taiwan

5. Ph.D. Program in Translational Medicine, Rong Hsing Research Center for Translational Medicine National Chung Hsing University Taichung Taiwan

6. Department of Dermatology Emory University School of Medicine, Winship Cancer Institute, Atlanta Veterans Administration Health Center Atlanta Georgia USA

7. Department of Molecular and Translational Medicine University of Brescia Brescia Lombardia Italy

8. Humanitas Clinical and Research Center IRCCS Rozzano Lombardia Italy

Funder

National Chung-Hsing University

National Science Council

Taichung Veterans General Hospital

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15806

Reference60 articles.

1. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets

2. Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology

3. The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein

4. NCBI GEO: archive for functional genomics data sets—update

5. The Use and Misuse of Penh in Animal Models of Lung Disease

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barleriside A, an aryl hydrocarbon receptor antagonist, ameliorates podocyte injury through inhibiting oxidative stress and inflammation;Frontiers in Pharmacology;2024-08-22

2. Aryl Hydrocarbon Receptor Activation in Pulmonary Alveolar Epithelial Cells Limits Inflammation and Preserves Lung Epithelial Cell Integrity;The Journal of Immunology;2024-07-19

3. AHR activation accelerates the resolution of TGF-β1 induced fibroblast activation and promotes alveolar type 1 cell regeneration in alveolar organoids;2024-05-02

4. Research on the mechanism of adipose tissue-derived stromal cell-extracellular vesicles to treat oral submucous fibrosis by blocking the TGF-β1/Smad3 pathway via the miR-760-3p/IGF1R axis;Biomolecules and Biomedicine;2023-12-04

5. Pulmonary Fibrosis; Risk Factors and Molecular Triggers, Insight for Neo Therapeutic Approach;Current Respiratory Medicine Reviews;2022-11